Not Tagged
gilead sciences
['breast', 'gilead sciences']
today at #asco22 we announced new positive study data in heavily pre-treated hr+/her2- metastatic breast cancer. 
The impossible is not impossible. It’s simply what hasn’t been achieved yet. Twitter guidelines: https://t.co/vWkdtfUf7N